The taxonomic composition of the donor intestinal microbiota is a major factor influencing the efficacy of faecal microbiota transplantation in therapy refractory ulcerative colitis

被引:150
|
作者
Kump, P. [1 ,2 ]
Wurm, P. [2 ,3 ]
Groechenig, H. P. [4 ]
Wenzl, H. [1 ]
Petritsch, W. [1 ]
Halwachs, B. [2 ,3 ,5 ]
Wagner, M. [1 ]
Stadlbauer, V. [1 ]
Eherer, A. [1 ]
Hoffmann, K. M. [6 ]
Deutschmann, A. [6 ]
Reicht, G. [7 ]
Reiter, L. [7 ]
Slawitsch, P. [7 ]
Gorkiewicz, G. [2 ,3 ,5 ]
Hoegenauer, C. [1 ,2 ,5 ]
机构
[1] Med Univ Graz, Dept Internal Med, Div Gastroenterol & Hepatol, Graz, Austria
[2] Med Univ Graz, Theodor Escherich Lab Med Microbiome Res, Graz, Austria
[3] Med Univ Graz, Inst Pathol, Graz, Austria
[4] Barmherzige Bruder Hosp, St Veit An Der Glan, Austria
[5] Interuniv Cooperat, BioTechMed Graz, Graz, Austria
[6] Med Univ Graz, Dept Pediat & Adolescent Med, Graz, Austria
[7] Barmherzige Bruder Hosp, Graz, Austria
基金
奥地利科学基金会;
关键词
EVIDENCE-BASED CONSENSUS; RNA GENE DATABASE; COMBINATION THERAPY; MAINTENANCE; REMISSION; COLONIZATION; METAANALYSIS; MANAGEMENT; INDUCTION; DIAGNOSIS;
D O I
10.1111/apt.14387
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BackgroundFaecal microbiota transplantation is an experimental approach for the treatment of patients with ulcerative colitis. Although there is growing evidence that faecal microbiota transplantation is effective in this disease, factors affecting its response are unknown. AimsTo establish a faecal microbiota transplantation treatment protocol in ulcerative colitis patients, and to investigate which patient or donor factors are responsible for the treatment success. MethodsThis is an open controlled trial of repeated faecal microbiota transplantation after antibiotic pre-treatment (FMT-group, n=17) vs antibiotic pre-treatment only (AB-group, n=10) in 27 therapy refractory ulcerative colitis patients over 90days. Faecal samples of donors and patients were analysed by 16SrRNA gene-based microbiota analysis. ResultsIn the FMT-group, 10/17 (59%) of patients showed a response and 4/17 (24%) a remission to faecal microbiota transplantation. Response to faecal microbiota transplantation was mainly influenced by the taxonomic composition of the donor's microbiota. Stool of donors with a high bacterial richness (observed species remission 94693 vs no response 797 +/- 181 at 15367rps) and a high relative abundance of Akkermansia muciniphila (3.3 +/- 3.1% vs 0.1 +/- 0.2%), unclassified Ruminococcaceae (13.8 +/- 5.0% vs 7.5 +/- 3.7%), and Ruminococcus spp. (4.9 +/- 3.5% vs 1.0 +/- 0.7%) were more likely to induce remission. In contrast antibiotic treatment alone (AB-group) was poorly tolerated, probably because of a sustained decrease of intestinal microbial richness. ConclusionsThe taxonomic composition of the donor's intestinal microbiota is a major factor influencing the efficacy of faecal microbiota transplantation in ulcerative colitis patients. The design of specific microbial preparation might lead to new treatments for ulcerative colitis.
引用
收藏
页码:67 / 77
页数:11
相关论文
共 50 条
  • [21] Faecal microbiota transplantation in ultra-refractory ulcerative colitis: Retrospective analysis in a tertiary care centre
    Guerrero Garcia, A.
    Flores de Miguel, A.
    Sanchez Rodriguez, E.
    Rios Leon, R.
    Roy Arino, G.
    Del Campo Moreno, R.
    Albillos Martinez, A.
    Lopez-Sanroman, A.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S463 - S463
  • [22] Long-term results of 4.5 years of faecal microbiota transplantation for treatment of refractory ulcerative colitis
    Uygun, A.
    Karakaya, M. F.
    Erdal, H.
    Celebi, G.
    Sakin, Y. S.
    Artuk, C.
    Ozturk, K.
    Gulsen, M.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S045 - S045
  • [23] Effect of Intestinal Microbiota Transplantation on Intestinal Flora and Inflammatory Factor Levels in Patients with Ulcerative Colitis
    Wang, Zhi
    Yang, Li
    Sun, Shan
    INFECTION AND DRUG RESISTANCE, 2023, 16 : 1183 - 1191
  • [24] Effect of Intestinal Microbiota Transplantation on Intestinal Flora and Inflammatory Factor Levels in Patients with Ulcerative Colitis
    Kanang, Indah Lestari Daeng
    INFECTION AND DRUG RESISTANCE, 2023, 16 : 1713 - 1714
  • [25] Systematic review of donor and recipient predictive biomarkers of response to faecal microbiota transplantation in patients with ulcerative colitis
    Rees, Nia Paddison
    Shaheen, Walaa
    Quince, Christopher
    Tselepis, Chris
    Horniblow, Richard D.
    Sharma, Naveen
    Beggs, Andrew D.
    Iqbal, Tariq H.
    Quraishi, Mohammed Nabil
    EBIOMEDICINE, 2022, 81
  • [26] Fecal microbiota transplantation in refractory ulcerative colitis - a case report
    Moutinho, B. D.
    Baima, J. P.
    Rigo, F. F.
    Saad-Hossne, R.
    Rodrigues, J.
    Romeiro, F. G.
    Sassaki, L. Y.
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2019, 47 (02) : 1072 - 1079
  • [27] Response to faecal microbiota transplantation in ulcerative colitis is not sustained long term following induction therapy
    Haifer, Craig
    Saikal, Aiasha
    Paramsothy, Ramesh
    Kaakoush, Nadeem O.
    Leong, Rupert W.
    Borody, Thomas J.
    Kamm, Michael A.
    Paramsothy, Sudarshan
    GUT, 2021, 70 (11) : 2210 - 2211
  • [28] Fecal Microbiota Transplantation for Ulcerative Colitis: An Evolving Therapy
    Sood, Ajit
    Singh, Arshdeep
    Midha, Vandana
    Mahajan, Ramit
    Kao, Dina
    Rubin, David T.
    Bernstein, Charles N.
    CROHNS & COLITIS 360, 2020, 2 (04) : 1 - 7
  • [29] ROLE OF INTESTINAL MICROBIOTA TRANSPLANTATION FOR MAINTENANCE OF REMISSION IN ULCERATIVE COLITIS
    Singh, Sahib
    Mohan, Babu P.
    Sanaei, Omid
    Vinayek, Rakesh
    Dutta, Sudhir
    Dahiya, Dushyant Singh
    Bhat, Ishfaq
    Sharma, Neil
    Adler, Douglas G.
    GASTROENTEROLOGY, 2024, 166 (05) : S1535 - S1535
  • [30] Composition and diverse differences of intestinal microbiota in ulcerative colitis patients
    Zhu, Siying
    Han, Muzhou
    Liu, Simao
    Fan, Liqiaona
    Shi, Haiyun
    Li, Peng
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2022, 12